All In Biotech

Drug Trial Radar · NCT01828463

Dose Response Study of Nitisinone in Alkaptonuria

An International, Multicentre, Randomised, Open-label, No-treatment Controlled, Parallel-group, Dose-response Study to Investigate the Effect of Once Daily Nitisinone on 24-hour Urinary Homogentisic Acid Excretion in Patients With Alkaptonuria After 4 Weeks Treatment.

Last checked: Nov 19, 2026Latest source record: Jun 11, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

40

Actual

Start

May 2013

Primary completion

Oct 2013

Study completion Dec 2013

Sponsor

Lead sponsor
University of LiverpoolAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Liverpool University Hospitals NHS Foundation Trust
First posted
Apr 10, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

SONIA 1 is an international, multicentre, randomised, open-label, no-treatment controlled, parallel group, dose-response study to investigate the effect of once daily nitisinone on 24-hour urinary homogentisic acid excretion in patients with alkaptonuria after 4-weeks treatment. They study will identify the optimal dose to decrease urine homogentisic acid to near normal levels.

Conditions

  • Alkaptonuria

Interventions

  • NitisinoneDrug

    doses 1, 2, 4 \& 8 mg plus no treatment arm

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. dose of nitisinone that decreases urinary homogentisic acid to near normalTime frame: 4 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Royal Liverpool Hospital

    Liverpool, Merseyside, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.